Interestingly, ERK1/2 has been reported to have opposite roles in cancer: its activation has indeed been shown to either promote or inhibit cancer cell proliferation, depending on the intensity and duration of ERK signaling and on its interplay with other signaling pathway.41 This evidence concerns the gene MAPK3 and cancer.